Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,...
Reexamination Certificate
2011-07-19
2011-07-19
Kolker, Daniel E (Department: 1649)
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
C530S387300, C530S402000, C514S001100
Reexamination Certificate
active
07981423
ABSTRACT:
Disclosed are RAGE fusion proteins comprising RAGE polypeptide sequences linked to a second, non-RAGE polypeptide. The RAGE fusion protein may utilize a RAGE polypeptide domain comprising a RAGE ligand binding site and an interdomain linker directly linked to an immunoglobulin CH2 domain. Such fusion proteins may provide specific, high affinity binding to RAGE ligands. Also disclosed is the use of the RAGE fusion proteins as therapeutics for RAGE-mediated pathologies.
REFERENCES:
patent: 4867973 (1989-09-01), Goers et al.
patent: 5567677 (1996-10-01), Castensson et al.
patent: 5656261 (1997-08-01), Cerami et al.
patent: 5658570 (1997-08-01), Newman et al.
patent: 5747035 (1998-05-01), Presta et al.
patent: 5843725 (1998-12-01), Sledziewski et al.
patent: 5853703 (1998-12-01), Cerami et al.
patent: 5864018 (1999-01-01), Morser et al.
patent: 5891341 (1999-04-01), Li et al.
patent: 6007865 (1999-12-01), Cerami et al.
patent: 6018026 (2000-01-01), Sledziewski et al.
patent: 6225448 (2001-05-01), Tao et al.
patent: 6267958 (2001-07-01), Andya et al.
patent: 6291646 (2001-09-01), Sledziewski et al.
patent: 6300099 (2001-10-01), Sledziewski et al.
patent: 6323323 (2001-11-01), Sledziewski et al.
patent: 6380165 (2002-04-01), Al-Abed et al.
patent: 6440749 (2002-08-01), Cerami et al.
patent: 6465422 (2002-10-01), Schmidt et al.
patent: 6555340 (2003-04-01), Schmidt et al.
patent: 6555651 (2003-04-01), Stern et al.
patent: 6563015 (2003-05-01), Stern et al.
patent: 6670136 (2003-12-01), Schmidt
patent: 6677299 (2004-01-01), Stern et al.
patent: 6753150 (2004-06-01), Schmidt et al.
patent: 6761888 (2004-07-01), Schenk
patent: 6790443 (2004-09-01), Stern et al.
patent: 6825164 (2004-11-01), Stern et al.
patent: 6908741 (2005-06-01), Shahbaz
patent: 6939545 (2005-09-01), Jacobs et al.
patent: 6998125 (2006-02-01), Hanna et al.
patent: 7026444 (2006-04-01), Schmidt et al.
patent: 7081241 (2006-07-01), Schmidt et al.
patent: 7101838 (2006-09-01), Stern et al.
patent: 7125675 (2006-10-01), Schmidt et al.
patent: 7189830 (2007-03-01), Gillies et al.
patent: 7258857 (2007-08-01), Stern et al.
patent: 7470521 (2008-12-01), O'Keefe et al.
patent: 2001/0039256 (2001-11-01), Stern et al.
patent: 2001/0053357 (2001-12-01), Stern et al.
patent: 2002/0002203 (2002-01-01), Rahbar
patent: 2002/0006391 (2002-01-01), Smith et al.
patent: 2002/0013256 (2002-01-01), Rahbar et al.
patent: 2002/0022234 (2002-02-01), Al-Abed et al.
patent: 2002/0037496 (2002-03-01), Jacobson et al.
patent: 2002/0077293 (2002-06-01), Cahoon et al.
patent: 2002/0082273 (2002-06-01), Bush et al.
patent: 2002/0086282 (2002-07-01), Pillarisetti et al.
patent: 2002/0102604 (2002-08-01), Edwards et al.
patent: 2002/0106726 (2002-08-01), Schmidt et al.
patent: 2002/0116725 (2002-08-01), Stern et al.
patent: 2002/0122799 (2002-09-01), Stern et al.
patent: 2003/0144201 (2003-07-01), Tracey et al.
patent: 2004/0121372 (2004-06-01), Schmidt et al.
patent: 2004/0142391 (2004-07-01), Schmidt et al.
patent: 2004/0228855 (2004-11-01), Stern et al.
patent: 2005/0008649 (2005-01-01), Shin et al.
patent: 2005/0026811 (2005-02-01), Mjalli et al.
patent: 2005/0033017 (2005-02-01), Yamamoto et al.
patent: 2005/0129682 (2005-06-01), Schmidt et al.
patent: 2005/0170382 (2005-08-01), Stern et al.
patent: 2005/0244849 (2005-11-01), Pittman et al.
patent: 2006/0025789 (2006-02-01), O'Keefe
patent: 2006/0030527 (2006-02-01), Mjalli et al.
patent: 2006/0057679 (2006-03-01), O'Keefe et al.
patent: 2006/0078562 (2006-04-01), Mjalli et al.
patent: 2006/0084145 (2006-04-01), Anderson et al.
patent: 2006/0140933 (2006-06-01), Pittman et al.
patent: 2007/0014791 (2007-01-01), Schmidt et al.
patent: 2007/0099829 (2007-05-01), Stern et al.
patent: 2007/0167360 (2007-07-01), Yan et al.
patent: 2008/0019986 (2008-01-01), Stern et al.
patent: 2008/0045455 (2008-02-01), Mjalli et al.
patent: 2008/0075733 (2008-03-01), Mjalli
patent: 2008/0171701 (2008-07-01), Stern
patent: 2008/0199467 (2008-08-01), Mjalli et al.
patent: 2008/0207499 (2008-08-01), Barile
patent: 2008/0214453 (2008-09-01), Stern et al.
patent: 2009/0004190 (2009-01-01), Mjalli et al.
patent: 2009/0060925 (2009-03-01), Mjalli et al.
patent: 1 380 593 (2004-01-01), None
patent: 2219947 (2003-12-01), None
patent: WO 97/26913 (1779-07-01), None
patent: WO 97/39121 (1997-10-01), None
patent: WO 97/39125 (1997-10-01), None
patent: WO 98/22138 (1998-05-01), None
patent: WO 98/40071 (1998-09-01), None
patent: WO 99/07402 (1999-02-01), None
patent: WO 99/13912 (1999-03-01), None
patent: WO 99/18987 (1999-04-01), None
patent: WO 94/10308 (1999-05-01), None
patent: WO 99/45907 (1999-09-01), None
patent: WO 99/54485 (1999-10-01), None
patent: WO 00/18970 (2000-04-01), None
patent: WO 00/20458 (2000-04-01), None
patent: WO 00/20621 (2000-04-01), None
patent: WO 01/05422 (2001-01-01), None
patent: WO 01/12598 (2001-02-01), None
patent: WO 01/18060 (2001-03-01), None
patent: WO 01/29269 (2001-04-01), None
patent: WO 01/76584 (2001-10-01), None
patent: WO 01/79849 (2001-10-01), None
patent: WO 01/86002 (2001-11-01), None
patent: WO 01/92210 (2001-12-01), None
patent: WO 01/92892 (2001-12-01), None
patent: WO 02/14519 (2002-02-01), None
patent: WO 02/30889 (2002-04-01), None
patent: WO 02/066978 (2002-08-01), None
patent: WO 02/068636 (2002-09-01), None
patent: WO 2004/004661 (2004-01-01), None
patent: WO 2004/016229 (2004-02-01), None
patent: WO 2004/055055 (2004-07-01), None
patent: WO 2005/019429 (2005-03-01), None
patent: WO 2005/049852 (2005-06-01), None
patent: WO 2005/051995 (2005-06-01), None
patent: WO 2005/061538 (2005-07-01), None
patent: WO 2005/108584 (2005-11-01), None
patent: WO 2006/002971 (2006-01-01), None
patent: WO 2006/012373 (2006-02-01), None
patent: WO 2006/012415 (2006-02-01), None
patent: WO 2006/017643 (2006-02-01), None
patent: WO 2006/017647 (2006-02-01), None
patent: WO 2006/036922 (2006-04-01), None
patent: WO 06/119510 (2006-11-01), None
patent: WO 2007/094926 (2007-08-01), None
patent: WO 2007/130302 (2007-11-01), None
patent: WO 2008/157378 (2008-06-01), None
patent: WO 2008/100470 (2008-08-01), None
Chelius et al., “Formation of Pyroglutamic Acid from N-Terminal Glutamic Acid in Immunoglobulin Gamma Antibodies” Analytical Chemistry, 78:2370-2376, 2006.
Written Opinion of the International Search Authority for related PCT Application, PCT/US2007/010125, mailed Feb. 22, 2008.
Mohler, K. et al., Soluble Tumor Necrosis Factor (TNF) Receptors are Effective Therapeutic Agents in Lethal Endotoxemia and Function Simultaneously as Both TNF Carriers and TNF Antafonists, Journal of Immunology, vol. 151, No. 3, pp. 1548-1561, 1993.
International Search Report for related PCT Application, PCT/US2007/010125, mailed Feb. 22, 2008.
Patent Cooperation Treaty, International Search Report, International Application No. PCT/US2007/001686, mailed Aug. 29, 2007.
Patent Cooperation Treaty, International Search Report, International Application No. PCT/US2005/027705, mailed Nov. 10, 2005.
Jan. 11, 2008 Office Action issued in connection with U.S. Appl. No. 11/197,644.
Dec. 10, 2008 Office Action issued in connection with U.S. Appl. No. 11/197,644.
Feb. 3, 2009 Office Action issued in connection with U.S. Appl. No. 10/990,310.
Schmidt, Ann Marie et al., “Isolation and Characterization of Two Binding Proteins for Advanced Glycosylation End Products from Bovine Lung Which Are Present on the Endothelial Cell Surface,” The Journal of Biological Chemistry, pp. 14987-14997, vol. 267, No. 21, The American Society for Biochemistry and Molecular Biology, Inc., Jul. 25, 1992.
Wines, Bruce D. et al., “The IgG Fc Contains Distinct Fc Receptor (FcR) Binding Sites: The Leukocyte Receptors FcyRI and FcyRlla Bind to a Region in the Fc Distinct from That Recognized by Neonatal FcR and Protein A1 ,” The Journal of Immunology, 164: 5313-5318, The American Association of Immunologists, (2000).
Renard, C. et al., “Recombinant Advanced Glycation End Product Receptor Pharmacokinetics in Normal and Diabetic Rats,” Molecular Pharmacology, 52: 54-62, The American Society for
Mjalli Adnan M. M.
Rothlein Robert
Tian Ye E.
Webster Jeffrey C.
Emch Gregory S
Kilpatrick Townsend & Stockton LLP
Kolker Daniel E
Transtech Pharma, Inc.
LandOfFree
Rage fusion proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rage fusion proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rage fusion proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2670452